drugset / Trial / NCT00654706
Efficacy Study Exploring the Effects on Cognition of Sertindole Versus Comparator in Patients With Schizophrenia
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to explore the neurocognitive efficacy of Sertindole versus comparator in patients with schizophrenia using the MCCB.
Timeline
- Start
- 2008-03
- Primary completion
- 2010-01
- Completion
- 2010-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Quetiapine | Small molecule | 400 mg | Oral |
| Comparator | Quetiapine | Small molecule | 500 mg | Oral |
| Comparator | Quetiapine | Small molecule | 600 mg | Oral |
| Subject | Sertindole | Small molecule | 12 mg | Oral |
| Subject | Sertindole | Small molecule | 16 mg | Oral |
| Subject | Sertindole | Small molecule | 20 mg | Oral |